We have further explored the potential clinical relevance of the epigenetic silencing of ANKRD26 by correlating both the ANKRD26 gene expression and DNA methylation to obesity-related endophenotypes. Here, ANKRD26 is linked to obesity due to melanocortin 4 receptor deficiency.